USA Next!


Project partners

Norwegian Smart Care Cluster
Oslo Cancer Cluster
Life Science Cluster

Funding partners

Viken Fylkeskommune
Generalkonsulatene i USA

USA Next Health Industry Roadmap – your pathway to success in the world’s biggest market


The United States stands at the forefront of health innovation, presenting immense opportunities. However, navigating this dynamic landscape requires strategic insights and support. USA Next is the first-ever joint collaboration amongst Norway’s health clusters, dedicated to empowering Norwegian companies in their journey to the U.S. market. These include: Norway Health Tech, Norwegian Smart Care Cluster, The Life Science Cluster, and the Oslo Cancer Cluster.

Register here to get a copy of the Health Industry Roadmap to the USA

Over the past two years, the clusters, supported by Viken Fylkeskommune and in partnership with Innovation Norway, have worked to develop a tailored roadmap for the health & life science industry in Norway. This roadmap serves as your compass through the intricacies of the U.S., providing insights into regional strengths, diverse health systems, patient demographics, federal and state programs, reimbursement schemes, validation processes, the regulatory landscape, and whom to contact depending upon your needs.

As a member of one of the health clusters, you automatically gain access to this invaluable Roadmap by entering your information here, after which a copy will be sent directly to you.

If you’re not yet part of the health cluster system, please fill out your information and we will contact you to make sure you receive your copy of the Roadmap and to see whether we can further support your journey. You can use the same link here.

Your journey to success begins with informed decisions – let’s explore the possibilities together!


*Please note that from 2024, Viken Fylke becomes Østfold Fylke, Akershus Fylke, and Buskerud Fylke*


About the USA Next project

The main goal of this project is to increase exports and internationalization from Norway to the American market, enhance cooperation with Norwegian companies, organizations (R&D, hospitals) and relevant environments in the USA.

The four leading health clusters in Norway contribute to this project. Together we develop a regional and national cooperation to make a road map for the health industry in Norway and the Nordic countries.

USA Next Activities in 2023

📆 December: Launch of the Health Industry Roadmap to the USA. Financed by Viken Fylkeskommune.

📆 December 6th – 7th 2023: Nordic-American Healthcare Conference

📆 November 15th, 2023: How to establish or grow your business in the United States. Location: Oslo Science Park, 15:00 – 16:00

📆 October 8th – 11th, 2023: HLTH in Las Vegas: Trade fair and exhibition. Digital solutions.

📆 September 26th – 28th, 2023 – Matchmaking and Networking Events with Business Accelerator Resource Network (BARN) and Larkin Hoffman

📆 September 12th, 2023: Webinar US Insights: Navigating Home Care, Elderly Care, and Remote Care

📆 May 31st – June 2nd, 2023: Minneapolis: Visiting Minneapolis with the Norwegian ecosystem in health.

📆 May 9th, 2023 Webinar: Are you qualifying for funding, public support programs and partnerships in the US?

📆 May 2nd, 2023, Webinar: US Market Insights: Hospital Systems in the US- what you have to know for your partnering and market access strategy

📆 April 20th, 2023: Webinar: How does the US home-, remote-, and elderly care work?

📆 March 12th, 2023, Austin, Texas: SXSW Tech For Social Good.

📆 February 15th, 2023 at 12.30 in Health2B, Oslo Science Park: Partnering with Norwegian assets and American experts

📆 February 7th, 2023: Reality Check. Are You Customer and Global Partner Ready?


Previous activities 2022

📆 March 13-15, 2022: Global Health Security Innovation Week at SXSW

Organized by the Texas Global Health Security Innovation Consortium (TEXGHS) at the University of Texas at Austin, with Norway as a partner in. GHSIW 2022 was the world’s first conference focused on bringing together the health security and technology innovation communities to define and communicate today’s most pressing challenges in preventing, predicting, detecting, and responding to global health security threats. GHSIW 2022 was entirely virtual and included official events of South by Southwest 2022. Norway participated with 6 companies, one panelist (Tore Godal, HOD) and one key note speaker (Stephen McAdam, DNV).

📆 March 22, 2022: Interested in the US as a market? Is USA your next market?

Learning and planning is key before entering the US market. An introductory webinar for the cross-cluster project “USA Next” was held March 22nd. The edited version of the webinar is here: “USA Next” – The first step – The Life Science Cluster

📆 May 31, 2022: Select USA and USA Next 

The Embassy of the United States of America and the U.S. Commercial Service together with USA Next, invited to attend an Industry Session on Health & Life Science. The venue was the U.S. Embassy in Oslo.

Participants received an introduction to the U.S. Commercial Service,  SelectUSA, Investor Guide and Customized Research Reports, FDA Pathways and trends in investments and US business culture. This included a networking happening.

📆 September 9, 2022: Reality check – investor readiness?

This webinar was the first in the series of reality-checks in USA Next.


Background and objectives

Mapping and mobilization

  • Mapping and analyzing target groups in the United States, needs, preparations, analyzing input strategies
  • Map Norwegian companies with relevant technology, products and solutions – with an interest in the USA
  • Mapping the status, knowledge and opportunity of each company to understand their specific needs
  • Workshop with companies (grouped by development stage; product type) to understand their needs and goals
  • Prioritize states / regions and target groups for joint initiative, plan for contact

Development and implementation of tailor-made training programs

  • Expert dialogue meetings (pedagogical and interactive, courses tailored to different competence levels)
  • Targeted and thematic group activities, including matchmaking
  • 1: 1 Business Development Support (for selected companies based on their maturity)
  • Recommendations and strategy for market entry, including a specific plan for implementation

Internationalization plan – adapted to the individual company

  • Product: non-regulatory, medical equipment, medicine etc.
  • Needs identification, expectations and goals
  • Courses and training of the companies. Make them better equipped for the United States
  • About the US healthcare market, commercialism, economics, scaling and more


  • Develop value proposition towards American partners as a door opener
  • Introduce companies to relevant US partners
  • Matchmaking with company, design a strategy
  • Targeted approach for US investors
  • Completion of roadmap / method
  • Evaluate collaboration with other Nordic innovation actors (For example BIO Bridge)